Gastroenterology
Volume 137, Issue 2 , Pages 495-501 , August 2009

Increased Short- and Long-Term Risk of Inflammatory Bowel Disease After Salmonella or Campylobacter Gastroenteritis

  • Kim O. Gradel

      Affiliations

    • Department of Infectious Diseases, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • Department of Clinical Microbiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Hans L. Nielsen

      Affiliations

    • Department of Infectious Diseases, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • ,
  • Henrik C. Schønheyder

      Affiliations

    • Department of Clinical Microbiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • ,
  • Tove Ejlertsen

      Affiliations

    • Department of Clinical Microbiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • ,
  • Brian Kristensen

      Affiliations

    • Department of Clinical Microbiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    • ,
  • Henrik Nielsen

      Affiliations

    • Department of Infectious Diseases, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • Corresponding Author InformationReprint requests Address requests for reprints to: Henrik Nielsen, MD, DMSc, Department of Infectious Diseases, Mølleparkvej 4, Aalborg Hospital, Aarhus University Hospital, DK-9000 Aalborg, Denmark. fax: (45) 99 32 60 08

Received 12 December 2008 ,Accepted 2 April 2009.

References 

  1. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517
  2. Subramanian S, Campbell BJ, Rhodes JM. Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis. 2006;19:475–484
  3. Barnich N, Darfeuille-Michaud A. Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol. 2007;13:5571–5576
  4. Scanlan PD, Shanahan F, O'Mahony C, et al. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol. 2006;44:3980–3988
  5. Barnich N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli and Crohn's disease. Curr Opin Gastroenterol. 2007;23:16–20
  6. Stallmach A, Carstens O. Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Inflamm Bowel Dis. 2002;8:213–218
  7. Blaser MJ, Hoverson D, Ely IG, et al. Studies of Campylobacter jejuni in patients with inflammatory bowel disease. Gastroenterology. 1984;86:33–38
  8. Taylor-Robinson S, Miles R, Whitehead A, et al. Salmonella infection and ulcerative colitis. Lancet. 1989;1:1145
  9. Mylonaki M, Langmead L, Pantes A, et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol. 2004;16:775–778
  10. Kallinowski F, Wassmer A, Hofmann MA, et al. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease. Hepatogastroenterology. 1998;45:1552–1558
  11. Schumacher G, Kollberg B, Sandstedt B, et al. A prospective study of first attacks of inflammatory bowel disease and non-relapsing colitis (Microbiologic findings). Scand J Gastroenterol. 1993;28:1077–1085
  12. Weber P, Koch M, Heizmann WR, et al. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol. 1992;14:302–308
  13. Melby K, Kildebo S. Antibodies against Campylobacter jejuni/coli in patients suffering from campylobacteriosis or inflammatory bowel disease. NIPH Ann. 1988;11:47–52
  14. Blaser MJ, Miller RA, Lacher J, et al. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology. 1984;87:888–894
  15. Boyanova L, Gergova G, Spassova Z, et al. Campylobacter infection in 682 Bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases. Diagn Microbiol Infect Dis. 2004;49:71–74
  16. Bayerdorffer E, Hochter W, Schwarzkopf-Steinhauser G, et al. Bioptic microbiology in the differential diagnosis of enterocolitis. Endoscopy. 1986;18:177–181
  17. De Hertogh G, Aerssens J, Geboes KP, et al. Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol. 2008;14:845–852
  18. Helms M, Simonsen J, Mølbak K. Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis. 2006;42:498–506
  19. Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006;130:1588–1594
  20. Ternhag A, Torner A, Svensson A, et al. Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis. 2008;14:143–148
  21. Pedersen CB, Gøtzsche H, Møller JO, et al. The Danish Civil Registration System (A cohort of eight million persons). Dan Med Bull. 2006;53:441–449
  22. Gradel KO, Schønheyder HC, Dethlefsen C, et al. Morbidity and mortality of elderly patients with zoonotic Salmonella and Campylobacter: a population-based study. J Infect. 2008;57:214–222
  23. Andersen TF, Madsen M, Jørgensen J, et al. The Danish National Hospital Register (A valuable source of data for modern health sciences). Dan Med Bull. 1999;46:263–268
  24. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  25. Blom M, Meyer A, Gerner-Smidt P, et al. Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol. 1999;37:2312–2316
  26. Engberg J, On SL, Harrington CS, et al. Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. J Clin Microbiol. 2000;38:286–291
  27. Popoff MY, Le Minor L. Antigenic formulas of the Salmonella serovars (WHO Collaborating Centre for Reference and Research on Salmonella). Paris, France: Institut Pasteur; 1997;
  28. Gradel KO, Dethlefsen C, Schønheyder HC, et al. Severity of infection and seasonal variation of non-typhoid Salmonella occurrence in humans. Epidemiol Infect. 2007;135:93–99
  29. Symons MJ, Moore DT. Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol. 2002;55:893–899
  30. Banks BM, Korelitz BI, Zetzel L. The course of nonspecific ulcerative colitis: review of twenty years experience and late results. Gastroenterology. 1957;32:983–1012
  31. Voetsch AC, Van Gilder TJ, Angulo FJ, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004;38(Suppl 3):S127–S134
  32. Wheeler JG, Sethi D, Cowden JM, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance (The Infectious Intestinal Disease Study Executive). BMJ. 1999;318:1046–1050
  33. Simonsen J, Strid MA, Mølbak K, et al. Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans. Epidemiol Infect. 2008;136:895–902
  34. Fonager K, Sørensen HT, Rasmussen SN, et al. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol. 1996;31:154–159
  35. Lewis JD, Brensinger C, Bilker WB, et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf. 2002;11:211–218
  36. Rothman KJ. Epidemiology: an introduction. Oxford, UK: Oxford University Press, Inc; 2002;

 Conflicts of interest The authors disclose no conflicts.

PII: S0016-5085(09)00524-1

doi: 10.1053/j.gastro.2009.04.001

Gastroenterology
Volume 137, Issue 2 , Pages 495-501 , August 2009

Article Tools

* Image Usage & Resolution